Axogen announced the appointment of Jens Schroeder Kemp to the newly created role of Chief Marketing Officer. As a member of the Axogen executive leadership team, Kemp will report directly to Karen Zaderej, Chairman, CEO and President, and will oversee the development and execution of the company’s marketing strategies. Mr. Kemp most recently served as Vice President of Marketing for Ambu Inc, where he led Ambu’s marketing efforts to create the single use endoscopy market across multiple clinical applications.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AXGN:
- Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
- Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
- AxoGen sees FY22 revenue $138.5M, consensus $139.05M
- AxoGen sees Q4 revenue $36.1M, consensus $36.52M
- AxoGen announces independent publication on allograft, autograft, conduits